Table A2.
VOLUME | DENSITY | PERVIOUSNESS | HETEROGENEITY | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Volume (per 0.1 mL) |
NCCT Median (per 10 HU) |
TAIQ1
(per 10 HU) |
TAIQ2 (per 10 HU) |
TAIQ3 (per 10 HU) |
TAIMCC (per 10 HU) |
CTA Median (per 10 HU) |
CTA SD (per 10 HU) |
NCCT SD (per 10 HU) |
||
Functional Outcome |
Registry |
0.90 † (0.86–0.95) |
0.96 (0.86–1.07) |
1.14 † (1.07–1.22) |
1.10 † (1.04–1.16) |
1.06 † (1.02–1.10) |
1.11 † (1.05–1.18) |
1.09 † (1.04–1.15) |
0.93 † (0.86–0.99) |
0.85 † (0.75–0.96) |
NO IV | 0.91 (0.81–1.02) |
1.15 (0.82–1.62) |
1.20 † (1.01–1.44) |
1.22 † (1.04–1.42) |
1.16 † (1.02–1.30) |
1.17 † (1.01–1.35) |
1.23 † (1.06–1.44) |
1.14 (0.94–1.40) |
0.76 (0.53–1.09) |
|
FPS | Registry |
0.93 † (0.87–0.99) |
0.96 (0.83–1.12) |
1.11 † (1.00–1.22) |
1.06 (0.98–1.15) |
1.02 (0.97–1.08) |
1.09 † (1.00–1.19) |
1.05 (0.97–1.14) |
1.03 (0.94–1.13) |
0.96 (0.84–1.11) |
NO IV | 0.91 (0.79–1.04) |
0.68 (0.44–1.04) |
1.02 (0.82–1.27) |
1.09 (0.90–1.32) |
1.13 (0.97–1.32) |
1.09 (0.90–1.31) |
1.01 (0.84–1.21) |
1.03 (0.81–1.31) |
0.54 † (0.30–0.97) |
|
eTICI2b+ | Registry | 1.01 (0.95–1.06) |
0.93 (0.82–1.06) |
0.96 (0.89–1.03) |
0.96 (0.91–1.03) |
0.98 (0.94–1.03) |
0.98 (0.92–1.05) |
0.95 (0.89–1.01) |
0.96 (0.88–1.04) |
0.87 † (0.77–0.98) |
NO IV | 1.05 (0.88–1.24) |
1.15 (0.69–1.90) |
0.93 (0.72–1.21) |
0.95 (0.76–1.19) |
0.97 (0.82–1.16) |
0.99 (0.79–1.23) |
0.98 (0.79–1.22) |
1.01 (0.76–1.36) |
0.76 (0.47–1.24) |